(Q43991259)

English

Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

chemoradiotherapy

0 references

esophageal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Yasumasa Nishimura

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Minoru Suzuki

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Kiyoshi Nakamatsu

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Shuichi Kanamori

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Yukinobu Yagyu

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Hironori Shigeoka

6

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

language of work or name

0 references

publication date

1 May 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

53

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

134-139

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902813-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902813-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902813-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus: a preliminary analysis of the phase II intergroup trial 0122

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902813-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902813-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902813-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent radiotherapy and chemotherapy with protracted continuous infusion of 5-fluorouracil in inoperable esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902813-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of chemoradiotherapy for advanced squamous cell carcinoma of the thoracic esophagus: nine Japanese institutions trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902813-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined modality therapy for esophageal carcinoma: Preliminary results from a large Australasian multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902813-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902813-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Esophageal cancer treated with radiotherapy: impact of total treatment time and fractionation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902813-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Late course accelerated fractionation in radiotherapy of esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902813-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(01)02813-9

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43991259&oldid=2105378134"